PLA2G2A and acute respiratory distress syndrome: Levels of sPLA2 activity in bronchoalveolar fluid (BALF) of patients with ARDS are often positively correlated with disease severity [11–14], and chemical sPLA2 inhibitors that block classical sPLA2s protect animals against experimental ARDS or related lung injury [15].